🫁 Revised Geneva Score (PE Probability)
Estimate pulmonary embolism pre-test probability with the objective revised Geneva score.
Uses only objective variables, reducing inter-rater variability.
Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.
When to use
An entirely objective alternative to Wells for suspected PE.
How it works
Weighted items (prior VTE 3, leg pain 3, HR 75–94 3 / ≥95 5, surgery/fracture 2, malignancy 2, haemoptysis 2, age >65 1, palpation pain + oedema 4). 0–3 low, 4–10 intermediate, ≥11 high.
Key points
- Uses only objective variables, reducing inter-rater variability.
- Non-high probability → high-sensitivity D-dimer.
- High probability → CT pulmonary angiography.
References
Worked calculation
The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.
| Age > 65 | No |
|---|---|
| Previous DVT/PE | No |
| Surgery/fracture within 1 month | No |
| Active malignancy | No |
| Unilateral lower-limb pain | No |
| Haemoptysis | No |
| Heart rate | < 75 (0) |
| Pain on deep vein palpation + unilateral oedema | No |
→Revised Geneva0
- Probability：Low (~8% PE)
- Pathway：Non-high probability → high-sensitivity D-dimer; if negative, PE excluded.
| Age > 65 | Yes (+1) |
|---|---|
| Previous DVT/PE | Yes (+3) |
| Surgery/fracture within 1 month | Yes (+2) |
| Active malignancy | Yes (+2) |
| Unilateral lower-limb pain | Yes (+3) |
| Haemoptysis | Yes (+2) |
| Heart rate | ≥ 95 (5) |
| Pain on deep vein palpation + unilateral oedema | Yes (+4) |
→Revised Geneva22
- Probability：High (~74% PE)
- Pathway：High probability → CT pulmonary angiography.
Frequently asked questions
- What is Revised Geneva Score (PE Probability)?
- Estimate pulmonary embolism pre-test probability with the objective revised Geneva score.
- How is Revised Geneva Score (PE Probability) calculated? What is the core formula?
- Weighted items (prior VTE 3, leg pain 3, HR 75–94 3 / ≥95 5, surgery/fracture 2, malignancy 2, haemoptysis 2, age >65 1, palpation pain + oedema 4). 0–3 low, 4–10 intermediate, ≥11 high.
- When is Revised Geneva Score (PE Probability) used?
- An entirely objective alternative to Wells for suspected PE.
- What are the key clinical points for Revised Geneva Score (PE Probability)?
- Uses only objective variables, reducing inter-rater variability. Non-high probability → high-sensitivity D-dimer. High probability → CT pulmonary angiography.
- What are the limits and cautions when using Revised Geneva Score (PE Probability)?
- For licensed clinicians and clinical researchers. Interpret results with history, investigations and local protocols; not a diagnosis or prescription, and not a substitute for multidisciplinary decision-making or local guidelines.
- How is Revised Geneva Score (PE Probability) calculated in practice? Can you show a worked example?
- Inputs: Age > 65 No, Previous DVT/PE No, Surgery/fracture within 1 month No, Active malignancy No, Unilateral lower-limb pain No, Haemoptysis No, Heart rate < 75 (0), Pain on deep vein palpation + unilateral oedema No → Result: Revised Geneva 0（Probability: Low (~8% PE), Pathway: Non-high probability → high-sensitivity D-dimer; if negative, PE excluded.） Inputs: Age > 65 Yes (+1), Previous DVT/PE Yes (+3), Surgery/fracture within 1 month Yes (+2), Active malignancy Yes (+2), Unilateral lower-limb pain Yes (+3), Haemoptysis Yes (+2), Heart rate ≥ 95 (5), Pain on deep vein palpation + unilateral oedema Yes (+4) → Result: Revised Geneva 22（Probability: High (~74% PE), Pathway: High probability → CT pulmonary angiography.）